Forty-slice multidetector computed tomography for non-invasive diagnostic approach to coronary artery disease

Cattedra di Radiologia, Azienda Ospedaliera Universitaria, Policlinico Paolo Giaccone, Università degli Studi, Palermo.
Giornale italiano di cardiologia (2006) 08/2007; 8(8):508-18.
Source: PubMed


Multidetector computed tomography coronary angiography (MDCT-CA) is a non-invasive technique that clearly shows coronary anatomy and correctly identifies plaque location and morphology. In this study we assessed diagnostic accuracy of MDCT-CA in detectiong significant stenosis in patients with clinically relevant coronary tree disease.
. Fifty patients (38 males, 12 females, mean age 60.9 +/- 9.2 years) with atypical chest pain, stable or unstable angina pectoris, or non-ST-elevation myocardial infarction underwent MDCT-CA (Brilliance 40, Philips Medical Systems, Cleveland, OH, USA) within 3 days before diagnostic conventional coronary angiography. Inclusion criteria were sinus rhythm, heart rate <70 b/min, and ability to hold breath for more than 12 s. Exclusion criteria were known intolerance to contrast medium, serum creatinine >2 mg/dl, pregnancy, respiratory insufficiency, unstable clinical conditions, and severe heart failure. Beta-blockers were administered if heart rate was >70 b/min. To synchronize arrival of the contrast bolus (Iomeron 400, Bracco, Milan) in the coronary arteries with the start of the scan the bolus-tracking technique was used. Diagnostic accuracy was evaluated per segment, per vessel, and per patient.
Mean heart rate during examination was 61.9 +/- 6.2 b/min; 618 segments were evaluated. The assessment was impaired by respiratory artifacts only in 1 patient (2%). MDCT-CA showed good sensitivity, specificity, and positive and negative predictive values in detecting significant coronary artery stenosis (94, 94, 91, and 96% per segment; 91, 97, 95, and 92% per vessel; 100, 100, 100, and 100% per-patient, respectively).
Forty-slice MDCT-CA showed a good diagnostic capability in detecting significant coronary artery stenosis in patients referred to our institution for suspected or known significant coronary artery disease.

0 Reads
  • [Show abstract] [Hide abstract]
    ABSTRACT: Cardiovascular disease (CVD) is the leading cause of morbidity and mortality worldwide and, according to the predictive assessment of the WHO, it could become the first cause of death from 2050. The prevention of major cardio- and cerebrovascular events in asymptomatic subjects remains a serious public health challenge. The underlying pathology is usually atherosclerosis, which develops insidiously over many years and is usually advanced by the time symptoms occur. Data from large prospective studies have facilitated the identification of major atherosclerotic risk factors such as age, gender, smoking, high blood pressure, elevated total and LDL cholesterol levels and low HDL cholesterol concentrations. The fact that risk factors work in synergy to elevate CVD risk has been recognized for decades. However, high-risk individuals have largely been identified based on single risk factors. Since CVD is multifactorial, it is important in healthy individuals to estimate their "global" CV absolute risk. Many groups and organizations have worked to develop approaches to identify high-risk subjects using global risk algorithms. Scoring equations to predict those at an increased risk have been developed using multiple cardiovascular risk factors. Furthermore, currently it is possible to assess more precisely the extension of the disease even at an early stage of the atherosclerotic process. There are a number of measurements of preclinical atherosclerotic organ damage. However, in spite of the evidence of their prognostic relevance they are not widely used in clinical practice. The present monography analyzes the various aspects of the CVD: from its pathology and underlying risk factors to the various tools currently available to stratify the absolute global cardiovascular risk in asymptomatic subjects. Furthermore, it aims at evaluating the role of non-invasive evidence of preclinical atherosclerosis (such as increased carotid intima-media thickness) as a marker of additional risk in improving the cardiovascular stratification.
    No preview · Article · Jan 2012